Generate a comprehensive and actionable clinical summary paragraph for Patient 4fb6be80-0cc1-f448-abb4-079f13fb95e6 Heidenreich818 Jules135 male 1978-07-05 209 Hilll Esplanade Buckingham PA 00000. Summarize in a one A4 page length report patient's medical history, treatment course, and include relevant clinical information, advice, and a clear course of action. Ensure the summary is concise yet informative, enabling doctors to effectively engage with the patient and guide their ongoing care given this data information: Condition Medication review due (situation) Diagnosis Report History and physical note 1978-07-05 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1978-08-09 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1979-06-13 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1980-06-11 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1981-06-10 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1981-12-09 10:16:27+11:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1985-06-26 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1986-07-02 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1987-07-08 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1989-07-19 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1990-07-25 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1991-07-31 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1994-08-17 09:16:27+10:00 Condition Received certificate of high school equivalency (finding) Condition Full-time employment (finding) Condition Stress (finding) Diagnosis Report History and physical note 1996-08-28 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 1997-09-03 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2000-09-06 10:16:27+11:00 Condition Stress (finding) Diagnosis Report History and physical note 2003-09-10 09:16:27+10:00 Condition Medication review due (situation) Condition Body mass index 30+ - obesity (finding) Condition Stress (finding) Diagnosis Report History and physical note 2009-09-16 09:16:27+10:00 Condition Medication review due (situation) Diagnosis Report History and physical note 2012-09-19 09:16:27+10:00 Diagnosis Report History and physical note 2012-12-02 05:16:27+11:00 Condition Full-time employment (finding) Condition Severe anxiety (panic) (finding) Diagnosis Report History and physical note 2012-12-12 10:16:27+11:00 Condition Medication review due (situation) Condition Limited social contact (finding) Observation final Body Height 179 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 92.2 kg Observation final Body mass index (BMI) [Ratio] 28.77 kg/m2 Observation final Blood pressure panel with all children optional 77 mm[Hg] 131 mm[Hg] Observation final Heart rate 64 /min Observation final Respiratory rate 14 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 134.8 mg/dL Observation final Triglycerides 108.33 mg/dL Observation final Low Density Lipoprotein Cholesterol 84.51 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 28.62 mg/dL Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Observation final Total score [DAST-10] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2015-09-23T09:16:27+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2015-09-23 09:16:27+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2015-09-23 10:44:54+10:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2015-09-23 11:19:35+10:00 Diagnosis Report History and physical note 2015-09-23 09:16:27+10:00 Condition Viral sinusitis (disorder) Diagnosis Report History and physical note 2016-09-03 21:16:27+10:00 Condition Medication review due (situation) Condition Stress (finding) Observation final Body Height 179 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} Observation final Body Weight 97.3 kg Observation final Body mass index (BMI) [Ratio] 30.37 kg/m2 Observation final Blood pressure panel with all children optional 75 mm[Hg] 139 mm[Hg] Observation final Heart rate 73 /min Observation final Respiratory rate 14 /min Observation final Leukocytes [#/volume] in Blood by Automated count 6.3446 10*3/uL Observation final Erythrocytes [#/volume] in Blood by Automated count 3.9899 10*6/uL Observation final Hemoglobin [Mass/volume] in Blood 16.245 g/dL Observation final Hematocrit [Volume Fraction] of Blood by Automated count 41.637 % Observation final MCV [Entitic volume] by Automated count 84.713 fL Observation final MCH [Entitic mass] by Automated count 27.335 pg Observation final MCHC [Mass/volume] by Automated count 33.217 g/dL Observation final Erythrocyte distribution width [Entitic volume] by Automated count 43.339 fL Observation final Platelets [#/volume] in Blood by Automated count 256 10*3/uL Observation final Platelet distribution width [Entitic volume] in Blood by Automated count 207.73 fL Observation final Platelet mean volume [Entitic volume] in Blood by Automated count 11.125 fL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 7 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2018-07-11T09:16:27+10:00 Immunization completed Hep A, adult 2018-07-11T09:16:27+10:00 Diagnosis Report CBC panel - Blood by Automated count 2018-07-11 09:16:27+10:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2018-07-11 10:33:33+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2018-07-11 11:14:23+10:00 Diagnosis Report History and physical note 2018-07-11 09:16:27+10:00 Condition Viral sinusitis (disorder) Diagnosis Report History and physical note 2018-08-08 03:16:27+10:00 Condition Acute bronchitis (disorder) Diagnosis Report History and physical note 2019-01-07 22:16:27+11:00 Condition Medication review due (situation) Condition Part-time employment (finding) Observation final Body Height 179 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 94.2 kg Observation final Body mass index (BMI) [Ratio] 29.39 kg/m2 Observation final Blood pressure panel with all children optional 71 mm[Hg] 134 mm[Hg] Observation final Heart rate 78 /min Observation final Respiratory rate 12 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 200 mg/dL Observation final Triglycerides 143.25 mg/dL Observation final Low Density Lipoprotein Cholesterol 138.34 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 33.01 mg/dL Observation final Tobacco smoking status Observation final Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 2 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 {score} Observation final Total score [AUDIT-C] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2019-01-16T10:16:27+11:00 Immunization completed Hep A, adult 2019-01-16T10:16:27+11:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2019-01-16 10:16:27+11:00 Diagnosis Report Generalized anxiety disorder 7 item (GAD-7) 2019-01-16 11:12:28+11:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2019-01-16 11:52:28+11:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2019-01-16 12:32:08+11:00 Diagnosis Report History and physical note 2019-01-16 10:16:27+11:00 Condition Medication review due (situation) Condition Hyperlipidemia Condition Full-time employment (finding) Observation final Cholesterol [Mass/volume] in Serum or Plasma 274.1 mg/dL Observation final Triglycerides 199.84 mg/dL Observation final Low Density Lipoprotein Cholesterol 171.8 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 34.889 mg/dL Observation final Glucose [Mass/volume] in Blood 93.94 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 8 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.5126 mg/dL Observation final Calcium [Mass/volume] in Blood 8.98 mg/dL Observation final Sodium [Moles/volume] in Blood 136.89 mmol/L Observation final Potassium [Moles/volume] in Blood 4.38 mmol/L Observation final Chloride [Moles/volume] in Blood 108.75 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 27.85 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 85.083 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.3231 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.3711 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.4138 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.16505 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 68.176 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 43.171 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24.495 U/L Observation final Body Height 179 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} Observation final Body Weight 89.9 kg Observation final Body mass index (BMI) [Ratio] 28.05 kg/m2 Observation final Blood pressure panel with all children optional 78 mm[Hg] 135 mm[Hg] Observation final Heart rate 71 /min Observation final Respiratory rate 12 /min Observation final Tobacco smoking status Observation final Total score [HARK] 0 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [DAST-10] 1 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2020-07-15T09:16:27+10:00 Immunization completed Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 2020-07-15T09:16:27+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2020-07-15 09:16:27+10:00 Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2020-07-15 09:16:27+10:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2020-07-15 10:33:22+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2020-07-15 11:16:47+10:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2020-07-15 11:48:38+10:00 Diagnosis Report History and physical note 2020-07-15 09:16:27+10:00 Diagnosis Report History and physical note 2020-08-05 09:16:27+10:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 2021-04-14T09:16:27+10:00 Diagnosis Report History and physical note 2021-04-14 09:16:27+10:00 Immunization completed SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose 2021-05-05T09:16:27+10:00 Diagnosis Report History and physical note 2021-05-05 09:16:27+10:00 Observation final Glucose [Mass/volume] in Blood 99.32 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 9.5 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.5674 mg/dL Observation final Calcium [Mass/volume] in Blood 9.39 mg/dL Observation final Sodium [Moles/volume] in Blood 142.82 mmol/L Observation final Potassium [Moles/volume] in Blood 3.96 mmol/L Observation final Chloride [Moles/volume] in Blood 104.73 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 27.25 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 66.699 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 6.2079 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 5.4053 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.2711 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.5613 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 73.487 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24.62 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21.196 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 171.56 mg/dL Observation final Triglycerides 105.88 mg/dL Observation final Low Density Lipoprotein Cholesterol 147.79 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 64.405 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2021-08-05 09:16:27+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2021-08-05 09:16:27+10:00 Diagnosis Report History and physical note 2021-08-05 09:16:27+10:00 Observation final Body Height 179 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} Observation final Body Weight 94.6 kg Observation final Body mass index (BMI) [Ratio] 29.54 kg/m2 Observation final Blood pressure panel with all children optional 71 mm[Hg] 131 mm[Hg] Observation final Heart rate 70 /min Observation final Respiratory rate 16 /min Observation final Cholesterol [Mass/volume] in Serum or Plasma 195.86 mg/dL Observation final Triglycerides 144.18 mg/dL Observation final Low Density Lipoprotein Cholesterol 137.77 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 29.25 mg/dL Observation final Tobacco smoking status Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 {score} Observation final Total score [AUDIT-C] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2022-07-06T09:16:27+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2022-07-06 09:16:27+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2022-07-06 10:25:48+10:00 Diagnosis Report Alcohol Use Disorder Identification Test - Consumption [AUDIT-C] 2022-07-06 11:08:59+10:00 Diagnosis Report History and physical note 2022-07-06 09:16:27+10:00 Condition Streptococcal sore throat (disorder) Observation final Body temperature 38.847 Cel Diagnosis Report History and physical note 2022-07-13 09:16:27+10:00 Condition Medication review due (situation) Condition Victim of intimate partner abuse (finding) Observation final Body Height 179 cm Observation final Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score} Observation final Body Weight 94.7 kg Observation final Body mass index (BMI) [Ratio] 29.57 kg/m2 Observation final Blood pressure panel with all children optional 75 mm[Hg] 136 mm[Hg] Observation final Heart rate 86 /min Observation final Respiratory rate 16 /min Observation final Tobacco smoking status Observation final Total score [HARK] 3 {score} Observation final Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 {score} Observation final Total score [DAST-10] 2 {score} Immunization completed Influenza, seasonal, injectable, preservative free 2022-07-20T09:16:27+10:00 Diagnosis Report Humiliation, Afraid, Rape, and Kick questionnaire [HARK] 2022-07-20 10:44:48+10:00 Diagnosis Report Patient Health Questionnaire 2 item (PHQ-2) [Reported] 2022-07-20 11:24:47+10:00 Diagnosis Report Drug Abuse Screening Test-10 [DAST-10] 2022-07-20 12:04:31+10:00 Diagnosis Report History and physical note 2022-07-20 09:16:27+10:00 Observation final Glucose [Mass/volume] in Blood 70.7 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 15.37 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.8917 mg/dL Observation final Calcium [Mass/volume] in Blood 9.53 mg/dL Observation final Sodium [Moles/volume] in Blood 142.17 mmol/L Observation final Potassium [Moles/volume] in Blood 5.03 mmol/L Observation final Chloride [Moles/volume] in Blood 110.18 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 25.44 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 73.06 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.1579 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.5312 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 3.2505 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.64537 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 109.15 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 46.53 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 6.4737 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 163.51 mg/dL Observation final Triglycerides 117.13 mg/dL Observation final Low Density Lipoprotein Cholesterol 82.276 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 73.781 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2022-08-05 09:16:27+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2022-08-05 09:16:27+10:00 Diagnosis Report History and physical note 2022-08-05 09:16:27+10:00 Observation final Glucose [Mass/volume] in Blood 74.12 mg/dL Observation final Urea nitrogen [Mass/volume] in Blood 12.22 mg/dL Observation final Creatinine [Mass/volume] in Blood 2.6218 mg/dL Observation final Calcium [Mass/volume] in Blood 8.6 mg/dL Observation final Sodium [Moles/volume] in Blood 136.4 mmol/L Observation final Potassium [Moles/volume] in Blood 4.83 mmol/L Observation final Chloride [Moles/volume] in Blood 108.11 mmol/L Observation final Carbon dioxide, total [Moles/volume] in Blood 25.99 mmol/L Observation final Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum or Plasma by Creatinine-based formula (MDRD) 71.188 mL/min Observation final Protein [Mass/volume] in Serum or Plasma 7.3335 g/dL Observation final Albumin [Mass/volume] in Serum or Plasma 3.974 g/dL Observation final Globulin [Mass/volume] in Serum by calculation 2.7334 g/L Observation final Bilirubin.total [Mass/volume] in Serum or Plasma 0.49544 mg/dL Observation final Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 60.488 U/L Observation final Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 43.508 U/L Observation final Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 11.063 U/L Observation final Cholesterol [Mass/volume] in Serum or Plasma 169.75 mg/dL Observation final Triglycerides 190.17 mg/dL Observation final Low Density Lipoprotein Cholesterol 98.886 mg/dL Observation final Cholesterol in HDL [Mass/volume] in Serum or Plasma 50.914 mg/dL Diagnosis Report Comprehensive metabolic 2000 panel - Serum or Plasma 2023-08-05 09:16:27+10:00 Diagnosis Report Lipid panel with direct LDL - Serum or Plasma 2023-08-05 09:16:27+10:00 Diagnosis Report History and physical note 2023-08-05 09:16:27+10:00